Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.

Dodick DW, Lipton RB, Ailani J, Halker Singh RB, Shewale AR, Zhao S, Trugman JM, Yu SY, Viswanathan HN.

Headache. 2020 Feb 19. doi: 10.1111/head.13766. [Epub ahead of print]

PMID:
32073660
2.

Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.

Ailani J.

J Fam Pract. 2020 Jan/Feb;69(1 Suppl). pii: jfp_6901v. No abstract available.

PMID:
32053719
3.

Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.

Dodick DW, Ailani J.

J Fam Pract. 2020 Jan/Feb;69(1 Suppl):S13-S22. No abstract available.

PMID:
32053715
4.

Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.

Ailani J, Lipton RB, Hutchinson S, Knievel K, Lu K, Butler M, Yu SY, Finnegan M, Severt L, Trugman JM.

Headache. 2020 Jan;60(1):141-152. doi: 10.1111/head.13682.

5.

Ubrogepant for the Treatment of Migraine.

Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A.

N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049.

PMID:
31800988
6.

The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.

Schwedt TJ, Digre K, Tepper SJ, Spare NM, Ailani J, Birlea M, Burish M, Mechtler L, Gottschalk C, Quinn AM, McGillicuddy L, Bance L, Dumkrieger G, Chong CD, Dodick DW.

Headache. 2020 Feb;60(2):337-347. doi: 10.1111/head.13688. Epub 2019 Nov 22.

PMID:
31755111
7.

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.

Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, Trugman JM.

JAMA. 2019 Nov 19;322(19):1887-1898. doi: 10.1001/jama.2019.16711.

PMID:
31742631
8.

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies.

Detke HC, Millen BA, Zhang Q, Samaan K, Ailani J, Dodick DW, Aurora SK.

Headache. 2020 Feb;60(2):348-359. doi: 10.1111/head.13691. Epub 2019 Nov 11.

PMID:
31710104
9.

Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double-blind studies.

Ailani J, Pearlman E, Zhang Q, Nagy AJ, Schuh K, Aurora SK.

Eur J Neurol. 2020 Mar;27(3):542-549. doi: 10.1111/ene.14102. Epub 2019 Dec 10.

PMID:
31595600
10.

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Lipton RB, Hutchinson S, Ailani J, Reed ML, Fanning KM, Manack Adams A, Buse DC.

Headache. 2019 Nov;59(10):1762-1772. doi: 10.1111/head.13642. Epub 2019 Sep 22.

11.

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.

Loo LS, Ailani J, Schim J, Baygani S, Hundemer HP, Port M, Krege JH.

J Headache Pain. 2019 Jul 24;20(1):84. doi: 10.1186/s10194-019-1032-x.

12.

Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache.

Halker Singh RB, Ailani J, Robbins MS.

Headache. 2019 Jul;59 Suppl 2:33-49. doi: 10.1111/head.13586. Review.

PMID:
31291017
13.

Traditional and Novel Migraine Therapy in the Aging Population.

Mathew S, Ailani J.

Curr Pain Headache Rep. 2019 May 11;23(6):42. doi: 10.1007/s11916-019-0789-6. Review.

PMID:
31079259
14.

A Review of Spontaneous Intracranial Hypotension.

Upadhyaya P, Ailani J.

Curr Neurol Neurosci Rep. 2019 Mar 19;19(5):22. doi: 10.1007/s11910-019-0938-7. Review.

PMID:
30888542
15.

Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

Stauffer VL, Dodick DW, Zhang Q, Carter JN, Ailani J, Conley RR.

JAMA Neurol. 2018 Sep 1;75(9):1080-1088. doi: 10.1001/jamaneurol.2018.1212. Erratum in: JAMA Neurol. 2019 Jul 1;76(7):872.

16.

An Up to Date Review of Pseudotumor Cerebri Syndrome.

Burkett JG, Ailani J.

Curr Neurol Neurosci Rep. 2018 May 2;18(6):33. doi: 10.1007/s11910-018-0839-1. Review.

PMID:
29721718
17.

A Clinical Approach to Addressing Diet with Migraine Patients.

Slavin M, Ailani J.

Curr Neurol Neurosci Rep. 2017 Feb;17(2):17. doi: 10.1007/s11910-017-0721-6. Review.

PMID:
28229401
18.

An Unusual Case of Post-Traumatic Headache Complicated by Intracranial Hypotension.

Siavoshi S, Dougherty C, Ailani J, Yadwadkar K, Berkowitz F.

Brain Sci. 2016 Dec 29;7(1). pii: E3. doi: 10.3390/brainsci7010003.

19.

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program.

Lipton RB, Rosen NL, Ailani J, DeGryse RE, Gillard PJ, Varon SF.

Cephalalgia. 2016 Aug;36(9):899-908. doi: 10.1177/0333102416652092. Epub 2016 Jun 10.

20.

A Practical Approach to Autonomic Dysfunction in Patients with Headache.

Ailani J.

Curr Neurol Neurosci Rep. 2016 May;16(5):41. doi: 10.1007/s11910-016-0641-x. Review.

PMID:
27021770
21.

The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.

Robbins MS, Robertson CE, Kaplan E, Ailani J, Charleston L 4th, Kuruvilla D, Blumenfeld A, Berliner R, Rosen NL, Duarte R, Vidwan J, Halker RB, Gill N, Ashkenazi A.

Headache. 2016 Feb;56(2):240-58. doi: 10.1111/head.12729. Epub 2015 Nov 30. Review.

PMID:
26615983
22.

Procedural Headache Medicine in Neurology Residency Training: A Survey of US Program Directors.

Robbins MS, Robertson CE, Ailani J, Levin M, Friedman DI, Dodick DW.

Headache. 2016 Jan;56(1):79-85. doi: 10.1111/head.12695. Epub 2015 Sep 9.

PMID:
26352267
23.

Systematic Review of Preventive and Acute Treatment of Menstrual Migraine.

Nierenburg Hdel C, Ailani J, Malloy M, Siavoshi S, Hu NN, Yusuf N.

Headache. 2015 Sep;55(8):1052-71. doi: 10.1111/head.12640. Epub 2015 Aug 12. Review.

PMID:
26264117
24.

Diagnose and adios: practical tips for the ongoing evaluation and care of TAC patients taking indomethacin.

Xanders LB, Ailani J.

Curr Pain Headache Rep. 2015;19(2):470. doi: 10.1007/s11916-014-0470-z. Review.

PMID:
25501954
25.

Migraine and patent foramen ovale.

Ailani J.

Curr Neurol Neurosci Rep. 2014 Feb;14(2):426. doi: 10.1007/s11910-013-0426-4. Review.

PMID:
24402405
26.

Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review.

Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R, Ailani J, Schim J, Friedman DI, Charleston L 4th, Young WB, Robertson CE, Dodick DW, Silberstein SD, Robbins MS.

Headache. 2013 Mar;53(3):437-46. doi: 10.1111/head.12053. Epub 2013 Feb 13. Review.

PMID:
23406160
27.

Tension-type headache and women: do sex hormones influence tension-type headache?

Ailani J.

Curr Pain Headache Rep. 2010 Dec;14(6):436-40. doi: 10.1007/s11916-010-0144-4. Review.

PMID:
20872187
28.

Chronic tension-type headache.

Ailani J.

Curr Pain Headache Rep. 2009 Dec;13(6):479-83. Review.

PMID:
19889291
29.

The role of nerve blocks and botulinum toxin injections in the management of cluster headaches.

Ailani J, Young WB.

Curr Pain Headache Rep. 2009 Apr;13(2):164-7. Review.

PMID:
19272284

Supplemental Content

Loading ...
Support Center